Local conformational changes in the catalytic core of the trans-acting hepatitis delta virus ribozyme accompany satalys

被引:63
|
作者
Harris, DA [1 ]
Rueda, D [1 ]
Walter, NG [1 ]
机构
[1] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA
关键词
D O I
10.1021/bi026101m
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The hepatitis delta virus (HDV) is a human pathogen and satellite RNA of the hepatitis B virus. It utilizes a self-cleaving catalytic RNA motif to process multimeric intermediates in the double-rolling circle replication of its genome. Previous kinetic analyses have suggested that a particular cytosine residue (C-75) with a pK(a) close to neutrality acts as a general acid or base in cleavage chemistry. The crystal structure of the product form of a cis-acting HDV ribozyme shows this residue positioned close to the 5'-OH leaving group of the reaction by a trefoil turn in the RNA backbone. By modifying G(76) of the trefoil turn of a synthetic trans-cleaving HDV ribozyme to the fluorescent 2-aminopurine (AP), we can directly monitor local conformational changes in the catalytic core. In the ribozyme-substrate complex (precursor), AP fluorescence is strongly quenched, suggesting that AP(76) is stacked with other bases and that the trefoil turn is not formed. In contrast, formation of the product complex upon substrate cleavage or direct product binding results in a significant increase in fluorescence, consistent with AP(76) becoming unstacked and solvent-exposed as evidenced in the trefoil turn. Using AP fluorescence and fluorescence resonance energy transfer (FRET) in concert, we demonstrate that this local conformational change in the trefoil turn is kinetically coincidental with a previously observed global structural change of the ribozyme. Our data show that, at least in the trans-acting HDV ribozyme, C-75 becomes positioned for reaction chemistry only along the trajectory from precursor to product.
引用
收藏
页码:12051 / 12061
页数:11
相关论文
共 50 条
  • [21] Inhibition of the catalytic activity of trans-acting antigenomic δ ribozyme by selected antibiotics and their Cu2+ complexes
    Wrzesinski, Jan
    Brzezowska, Magdalena
    Szczepanik, Wojciech
    Jezowska-Bojczuk, Malgorzata
    Ciesiolka, Jerzy
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 349 (04) : 1394 - 1400
  • [22] Characterization of the catalytic Mg of the hepatitis delta virus ribozyme by Raman spectroscopy
    Gong, Bo
    Chen, Jui-Hui
    Golden, Barbara L.
    Bevilacqua, Philip C.
    Carey, Paul
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237 : 588 - 588
  • [23] Catalytic strategies of the hepatitis delta virus ribozyme as probed by molecular dynamics simulations
    不详
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2005, 22 (06): : 774 - 774
  • [24] Identification of the Catalytic Mg2+ Ion in the Hepatitis Delta Virus Ribozyme
    Chen, Ji
    Ganguly, Abir
    Miswan, Zulaika
    Hammes-Schiffer, Sharon
    Bevilacqua, Philip C.
    Golden, Barbara L.
    BIOCHEMISTRY, 2013, 52 (03) : 557 - 567
  • [25] Two Distinct Catalytic Strategies in the Hepatitis Delta Virus Ribozyme Cleavage Reaction
    Golden, Barbara L.
    BIOCHEMISTRY, 2011, 50 (44) : 9424 - 9433
  • [26] Cations and hydration in catalytic RNA:: Molecular dynamics of the hepatitis delta virus ribozyme
    Krasovska, Maryna V.
    Sefcikova, Jana
    Reblova, Kamila
    Schneider, Bohdan
    Walter, Nils G.
    Sponer, Jiri
    BIOPHYSICAL JOURNAL, 2006, 91 (02) : 626 - 638
  • [27] Mutational analysis of the antigenomic trans-acting delta ribozyme:: the alterations of the middle nucleotides located on the P1 stem
    Ananvoranich, S
    Lafontaine, DA
    Perreault, JP
    NUCLEIC ACIDS RESEARCH, 1999, 27 (06) : 1473 - 1479
  • [28] TRANS-ACTING FACTORS REGULATING THE REPLICATION AND MALIGNANT TRANSFORMATION OF HEPATITIS-B VIRUS
    ACS, G
    KARPEN, S
    BANERJEE, R
    SELLS, MA
    VAJTA, G
    PRICE, P
    SUNG, M
    LENGYEL, G
    SHVARTSMAN, M
    LIVER CELL CARCINOMA, 1989, 51 : 113 - 115
  • [29] Common conformational changes induced in type 2 picornavirus IRESs by cognate trans-acting factors
    Yu, Yingpu
    Abaeva, Irina S.
    Marintchev, Assen
    Pestova, Tatyana V.
    Hellen, Christopher U. T.
    NUCLEIC ACIDS RESEARCH, 2011, 39 (11) : 4851 - 4865
  • [30] Properties of antigenomic hepatitis delta virus ribozyme cis- and trans-analogs
    Savochkina, L
    Alekseenkova, V
    Belyanko, T
    Lukin, M
    Beabealashvilli, R
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2004, 23 (6-7): : 935 - 942